Formation and Investigation of Cell-Derived Nanovesicles as Potential Therapeutics against Chronic Liver Disease.

Ganguin, Aymar Abel; Skorup, Ivo; Streb, Sebastian; Othman, Alaa; Luciani, Paola

Ganguin, Aymar Abel; Skorup, Ivo; Streb, Sebastian; Othman, Alaa; Luciani, Paola.

Afiliación

Ganguin AA; Department of Chemistry, Biochemistry and Pharmaceutical Sciences, University of Bern, Bern, 3012, Switzerland.
Skorup I; Department of Chemistry, Biochemistry and Pharmaceutical Sciences, University of Bern, Bern, 3012, Switzerland.
Streb S; Functional Genomics Center Zurich (FGCZ), University of Zurich/ETH Zurich, Zurich, 8057, Switzerland.
Othman A; Functional Genomics Center Zurich (FGCZ), University of Zurich/ETH Zurich, Zurich, 8057, Switzerland.
Luciani P; Department of Chemistry, Biochemistry and Pharmaceutical Sciences, University of Bern, Bern, 3012, Switzerland.

Adv Healthc Mater ; 12(30): e2300811, 2023 12.

Article en En | MEDLINE | ID: mdl-37669775

Asunto(s)

Cirrosis Hepática; Hígado; Humanos; Cirrosis Hepática/tratamiento farmacológico; Hígado/metabolismo; Línea Celular; Fibrosis; Células Estrelladas Hepáticas/metabolismo; Células Estrelladas Hepáticas/patología

Palabras clave

LX-2 cells; cell-derived nanovesicles (cdNVs); corona; extracellular vesicles mimetics; liver fibrosis

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Hígado / Cirrosis Hepática Límite: Humans Idioma: En Revista: Adv Healthc Mater Año: 2023 Tipo del documento: Article País de afiliación: Suiza

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google